Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.

scientific article

Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1022837644
P356DOI10.1186/S12879-016-1443-0
P932PMC publication ID4778345
P698PubMed publication ID26939611
P5875ResearchGate publication ID297591683

P50authorĐorđe JevtovićQ73198113
P2093author name stringMargaret A Johnson
Mike Youle
Colette J Smith
Gordana Dragovic
Jovana Kusic
Bozana Dimitrijevic
P2860cites workTreatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study CohortQ30869874
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settingsQ33574798
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA studyQ34388139
Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA studyQ34420990
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV InfectionQ34485916
Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era.Q34663606
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studiesQ36285986
CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysisQ38864759
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve PatientsQ38959219
Comparison of nucleoside reverse transcriptase inhibitor use as part of first-line therapy in a Serbian and a UK HIV clinic.Q43228891
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.Q44456185
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyQ44506169
Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohortsQ45034368
CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use.Q51873827
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.Q53608173
An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment useQ57181250
CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials GroupQ77477023
Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patientsQ79290169
P921main subjectgross domestic productQ12638
P304page(s)106
P577publication date2016-03-03
P1433published inBMC Infectious DiseasesQ15759919
P1476titleChoice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study
P478volume16

Reverse relations

cites work (P2860)
Q39461592Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report
Q91862539Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines
Q38977712Lower levels of IL-4 and IL-10 influence lipodystrophy in HIV/AIDS patients under antiretroviral therapy.
Q37141406The growing HIV epidemic in Central Europe: a neglected issue?

Search more.